Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase

J Moravcová, V Zmeková, H Klamová, J Voglová… - Leukemia research, 2004 - Elsevier
Kinetics of BCR-ABL transcript levels were determined in 19 patients with chronic myeloid
leukemia (CML) treated with imatinib for chronic (CP) or accelerated phase (AP). Patients …
被引用次数：20 相关文章

Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase

J Moravcová, V Zmeková, H Klamová, J Voglová… - Leukemia Research, 2004 - infona.pl
Kinetics of BCR-ABL transcript levels were determined in 19 patients with chronic myeloid
leukemia (CML) treated with imatinib for chronic (CP) or accelerated phase (AP). Patients …

Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase.

J Moravcová, V Zmeková, H Klamová… - Leukemia …, 2004 - europepmc.org
Kinetics of BCR-ABL transcript levels were determined in 19 patients with chronic myeloid
leukemia (CML) treated with imatinib for chronic (CP) or accelerated phase (AP). Patients …

Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase

J Moravcová, V Zmeková, H Klamová… - Leukemia …, 2004 - pubmed.ncbi.nlm.nih.gov
Kinetics of BCR-ABL transcript levels were determined in 19 patients with chronic myeloid
leukemia (CML) treated with imatinib for chronic (CP) or accelerated phase (AP). Patients …

[引用][C] Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase

J MORAVCOVA, V ZMEKOVA, H KLAMOVA… - Leukemia research, 2004 - Elsevier